RCKT Latest Press Releases

-- June 12, 2026 --

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million Business Wire 7:00 AM

-- May 28, 2026 --

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire 7:00 AM

-- May 7, 2026 --

Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress Business Wire 4:00 PM

-- April 28, 2026 --

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher Business Wire 7:00 AM

-- March 27, 2026 --

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) Business Wire 7:00 AM

-- February 26, 2026 --

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress Business Wire 4:00 PM

-- February 23, 2026 --

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software